当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3252882
自主品牌
已选条件
-
T9912TrastuzumabEGFR,Trastuzumab,Anti-Human HER2, Humanized Antibody,Epidermal growth factor receptor,HER
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
价 格：￥电议型 号：T9912产 地：中国大陆
-
T80955Trastuzumab duocarmazine；化合物 Trastuzumab duocarmazine(vic)-Trastuzumab duocarmazine；(vic)-Trastuzuma
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is an ADC targeting HER2 that undergoes cleavage by histone B within tumor cells, thereby achieving selective targeting of these cells. It exhibits antitumor activity and is applicable in cancer research, particularly concerning uterine and ovarian sarcomas [1].
价 格：￥电议型 号：T80955产 地：中国大陆
-
T76971Trastuzumab beta；化合物 Trastuzumab betaTrastuzumab beta
Trastuzumab beta (ABP 980), a biosimilar to Trastuzumab, is a monoclonal antibody (McAb) that targets the human epidermal growth factor receptor 2 (HER2). It is utilized in the research of HER2-positive metastatic breast cancer, early breast cancer (EBC), and metastatic gastric cancer [1].
价 格：￥电议型 号：T76971产 地：中国大陆
-
T36647Trastuzumab emtansine；曲妥珠单抗-美坦新偶联物Trastuzumab emtansine
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that combines the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of DM1, a microtubule-inhibitory derivative of maytansine. This compound is utilized in the investigation of advanced breast cancer[1][2].
价 格：￥电议型 号：T36647产 地：中国大陆
-
T36646Trastuzumab deruxtecan；德曲妥珠单抗DS-8201a|||VRN-101099|||DS 8201|||T-DXd；DS-8201a|||VRN-101099|||DS 8201
Trastuzumab deruxtecan (T-DXd) is an antibody-activated molecule coupling (ADC) with anticancer and antitumour activity.Trastuzumab deruxtecan has been shown to have an ameliorative effect in HER2-positive breast and gastric cancers.
价 格：￥电议型 号：T36646产 地：中国大陆
